Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
1.67T | 1.60T | 1.70T | 1.76T | 1.31T | Gross Profit |
954.34B | 885.44B | 946.04B | 970.47B | 641.70B | EBIT |
528.94B | 504.38B | 592.76B | 640.63B | 352.37B | EBITDA |
698.75B | 515.41B | 603.29B | 651.43B | 361.93B | Net Income Common Stockholders |
490.60B | 432.77B | 477.69B | 480.38B | 258.64B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
2.25T | 1.88T | 1.71T | 1.74T | 1.22T | Total Assets |
3.15T | 2.85T | 2.66T | 2.45T | 1.93T | Total Debt |
6.13B | 6.29B | 6.23B | 5.77B | 2.16B | Net Debt |
-1.48T | -1.26T | -1.20T | -1.18T | -888.24B | Total Liabilities |
546.40B | 587.82B | 593.08B | 572.30B | 393.19B | Stockholders Equity |
2.60T | 2.27T | 2.07T | 1.87T | 1.54T |
Cash Flow | Free Cash Flow | |||
445.97B | 300.65B | 282.07B | 605.10B | 337.91B | Operating Cash Flow |
462.10B | 322.84B | 289.66B | 612.11B | 347.75B | Investing Cash Flow |
-630.63B | 111.51B | 93.70B | -136.53B | -188.43B | Financing Cash Flow |
-236.96B | -290.97B | -337.01B | -194.94B | -111.03B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | ¥2.81T | 36.18 | 17.62% | 0.76% | 22.76% | 50.11% | |
73 Outperform | $1.74T | 54.80 | 16.14% | 0.92% | -11.38% | -33.42% | |
72 Outperform | ¥626.97B | 16.01 | 10.45% | 1.62% | -5.84% | -16.40% | |
70 Outperform | $1.00T | 78.22 | 3.62% | 0.81% | 0.58% | -56.67% | |
69 Neutral | $14.39T | 45.00 | 12.13% | 0.88% | -27.51% | -35.35% | |
65 Neutral | ¥58.07B | 33.48 | 3.03% | 4.06% | 0.92% | 27.31% | |
59 Neutral | $13.76B | 7.65 | -2.18% | 3.85% | 2.32% | -36.56% |